Global Information
회사소개 | 문의 | 비교리스트

세계의 염증성 장질환 치료 시장 규모 조사 : 종류별, 약제 클래스별, 투여 경로별, 유통 채널별, 지역별 예측(2021-2027년)

Global Inflammatory Bowel Disease Treatment Market Size study, by By Type, By Drug Class By Route of Administration, By Distribution Channel and Regional Forecasts 2021-2027

리서치사 Bizwit Research & Consulting LLP
발행일 2021년 11월 상품 코드 1035943
페이지 정보 영문
가격
US $ 4,950 ₩ 5,952,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,515,000 Printable PDF (Enterprise License)


세계의 염증성 장질환 치료 시장 규모 조사 : 종류별, 약제 클래스별, 투여 경로별, 유통 채널별, 지역별 예측(2021-2027년) Global Inflammatory Bowel Disease Treatment Market Size study, by By Type, By Drug Class By Route of Administration, By Distribution Channel and Regional Forecasts 2021-2027
발행일 : 2021년 11월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 염증성 장질환 치료 시장 규모는 2020년에 약 192억 달러를 기록했습니다.

시장은 2021-2027년 예측기간에 4.8% 이상의 건전한 성장률로 확대될 것으로 예측됩니다.

크론병 및 궤양성 대장염 이환율 상승이 염증성 장질환 치료 시장을 견인하는 중요한 요인이 되고 있습니다. 환자수 증가에 의해 효과적인 치료법 수요가 증가하고 있습니다. Hyrimoz, Imraldi, Renflexis, Inflectra 등의 바이오시밀러 사용 허가가 증가하고 있고, 기존 치료법보다 우수하기 때문에 효과적인 치료법의 채용이 증가할 것으로 예측됩니다. 그러나 치료비가 높은 점이 2021-2027년 예측기간 중 시장 성장을 저해할 것으로 예측됩니다. 또한 고령자 인구 증가가 예측기간 중 시장 성장을 촉진할 것으로 생각됩니다.

세계의 염증성 장질환 치료(Inflammatory Bowel Disease Treatment) 시장에 대해 조사했으며, 시장 개요와 함께 종류별, 약제 클래스별, 투여 경로별, 유통 채널별, 지역별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 주요 요약

제2장 세계의 염증성 장질환 치료 시장 정의와 범위

제3장 세계의 염증성 장질환 치료 시장 역학

  • 염증성 장질환 치료 시장의 영향 분석(2019-2027년)

제4장 세계의 염증성 장질환 치료 시장 업계 분석

  • Porter's 5 Force 모델
  • PEST 분석
  • 투자 채용 모델
  • 애널리스트의 추천사항과 결론

제5장 세계의 염증성 장질환 치료 시장, 종류별

  • 시장 현황
  • 세계의 염증성 장질환 치료 시장, 종류별 : 실적 - 잠재성 분석
  • 세계의 염증성 장질환 치료 시장 견적과 예측, 종류별 : 2018-2027년(10억 달러)
  • 염증성 장질환 치료 시장, 하위 부문 분석
    • 크론병
    • 궤양성 대장염

제6장 세계의 염증성 장질환 치료 시장, 약제 클래스별

  • 시장 현황
  • 세계의 염증성 장질환 치료 시장, 약제 클래스별 : 실적 - 잠재성 분석
  • 세계의 염증성 장질환 치료 시장 견적과 예측, 약제 클래스별 : 2018-2027년(10억 달러)
  • 염증성 장질환 치료 시장, 하위 부문 분석
    • 아미노살리실산
    • 코르티코스테로이드
    • TNF 억제제
    • IL 억제제
    • 항인테그린
    • JAK 억제제
    • 기타

제7장 세계의 염증성 장질환 치료 시장, 투여 경로별

  • 시장 현황
  • 세계의 염증성 장질환 치료 시장, 투여 경로별 : 실적 - 잠재성 분석
  • 세계의 염증성 장질환 치료 시장 견적과 예측, 투여 경로별 : 2018-2027년(10억 달러)
  • 염증성 장질환 치료 시장, 하위 부문 분석
    • 경구
    • 주사

제8장 세계의 염증성 장질환 치료 시장, 유통 채널별

  • 시장 현황
  • 세계의 염증성 장질환 치료 시장, 유통 채널별 : 실적 - 잠재성 분석
  • 세계의 염증성 장질환 치료 시장 견적과 예측, 유통 채널별 : 2018-2027년(10억 달러)
  • 염증성 장질환 치료 시장, 하위 부문 분석
    • 원내 약국
    • 소매 약국
    • 온라인 약국

제9장 세계의 염증성 장질환 치료 시장, 지역 분석

  • 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽 현황
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타
  • 아시아태평양 현황
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타
  • 라틴아메리카 현황
    • 브라질
    • 멕시코
  • 기타 지역

제10장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • AbbVie Inc.
    • Biogen
    • Johnson & Johnson Services, Inc.
    • Amgen Inc.
    • UCB S.A.
    • Novartis AG
    • Takeda Pharmaceutical Company Limited
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Lilly

제11장 조사 과정

KSM 21.11.22

LIST OF TABLES

  • TABLE 1. Global Inflammatory Bowel Disease Treatment Market, report scope
  • TABLE 2. Global Inflammatory Bowel Disease Treatment Market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global Inflammatory Bowel Disease Treatment Market estimates & forecasts by Type 2018-2027 (USD Billion)
  • TABLE 4. Global Inflammatory Bowel Disease Treatment Market estimates & forecasts by Drug Class 2018-2027 (USD Billion)
  • TABLE 5. Global Inflammatory Bowel Disease Treatment Market estimates & forecasts by Route of Administration 2018-2027 (USD Billion)
  • TABLE 6. Global Inflammatory Bowel Disease Treatment Market estimates & forecasts by Distribution Channel 2018-2027 (USD Billion)
  • TABLE 7. Global Inflammatory Bowel Disease Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Inflammatory Bowel Disease Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Inflammatory Bowel Disease Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Inflammatory Bowel Disease Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Inflammatory Bowel Disease Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Inflammatory Bowel Disease Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Inflammatory Bowel Disease Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Inflammatory Bowel Disease Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Inflammatory Bowel Disease Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Inflammatory Bowel Disease Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. U.S. Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. U.S. Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 19. U.S. Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 20. Canada Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Canada Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. Canada Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. UK Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. UK Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. UK Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Germany Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. Germany Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. Germany Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. RoE Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. RoE Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. RoE Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. China Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. China Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. China Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. India Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. India Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. India Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Japan Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. Japan Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Japan Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. RoAPAC Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. RoAPAC Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. Brazil Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. Brazil Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. Brazil Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. Mexico Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. Mexico Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. Mexico Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. RoLA Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. RoLA Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. RoLA Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Row Inflammatory Bowel Disease Treatment Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. Row Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Row Inflammatory Bowel Disease Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. List of secondary sources, used in the study of global Inflammatory Bowel Disease Treatment Market
  • TABLE 57. List of primary sources, used in the study of global Inflammatory Bowel Disease Treatment Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Inflammatory Bowel Disease Treatment Market, research methodology
  • FIG 2. Global Inflammatory Bowel Disease Treatment Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Inflammatory Bowel Disease Treatment Market, key trends 2020
  • FIG 5. Global Inflammatory Bowel Disease Treatment Market, growth prospects 2021-2027
  • FIG 6. Global Inflammatory Bowel Disease Treatment Market, porters 5 force model
  • FIG 7. Global Inflammatory Bowel Disease Treatment Market, pest analysis
  • FIG 8. Global Inflammatory Bowel Disease Treatment Market, value chain analysis
  • FIG 9. Global Inflammatory Bowel Disease Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Inflammatory Bowel Disease Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Inflammatory Bowel Disease Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Inflammatory Bowel Disease Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Inflammatory Bowel Disease Treatment Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Inflammatory Bowel Disease Treatment Market, regional snapshot 2018 & 2027
  • FIG 15. North America Inflammatory Bowel Disease Treatment Market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Inflammatory Bowel Disease Treatment Market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Inflammatory Bowel Disease Treatment Market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Inflammatory Bowel Disease Treatment Market 2018 & 2027 (USD Billion)
  • FIG 19. Global Inflammatory Bowel Disease Treatment Market, company market share analysis (2020)

Global Inflammatory Bowel Disease Treatment Market is valued approximately USD 19.2 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.8 % over the forecast period 2021-2027. The term Inflammatory Bowel Disease is used for mainly two conditions Crohn's disease and ulcerative colitis. Increase in prevalence of Crohn's disease and ulcerative colitis is the key factor driving the market of inflammatory bowel disease treatment. According to the Crohn's and Colitis Foundation (CCFA), approximately 70,000 fresh cases of inflammatory bowel disease are investigated in the U.S. every year. As per the CCFA report of 2019, about 1.6 million cases were diagnosed in U.S with Inflammatory Bowel Disease. In Europe there were approximately 3.4 billion people were found with any form of IBD in 2020, according to the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA). Growing population of affected people are rising the demand for effective treatment options. Increasing permissions for biosimilars such as Hyrimoz, Imraldi, Renflexis, and Inflectra is projected to increase the adoption of effective treatment due to its advantages over traditional treatment methods. However, high cost of treatment is predicted to impede the growth of the market over the forecast period of 2021-2027. Also, increasing geriatric population is likely to increase the market growth during the forecast period.

The regional analysis of global Inflammatory Bowel Disease Treatment Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the dominating region across the world in terms of market share owing to increasing treatment rates, growing prescription of novel drugs, and better reimbursement policies are some factors affecting the market growth in the region. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. Factors such as growing Crohn's disease and ulcerative colitis in the region, increasing prescription of biosimilars, and rising novel drug approval would create lucrative growth prospects for the Inflammatory Bowel Disease Treatment Market across Asia-Pacific region.

Major market player included in this report are:

AbbVie Inc.

Biogen

Johnson & Johnson Services, Inc.

Amgen Inc.

UCB S.A.

Novartis AG

Takeda Pharmaceutical Company Limited

Merck & Co., Inc.

Pfizer Inc.

Lilly

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Crohn's Disease

Ulcerative Colitis

By Drug Class:

Aminosalicylates

Corticosteroids

TNF inhibitors

IL inhibitors

Anti-integrin

JAK inhibitors

Others

By Route of Administration:

Oral

Injectable

By Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Inflammatory Bowel Disease Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Inflammatory Bowel Disease Treatment Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Inflammatory Bowel Disease Treatment Market, by Type, 2019-2027 (USD Billion)
    • 1.2.3. Inflammatory Bowel Disease Treatment Market, by Drug Class, 2019-2027 (USD Billion)
    • 1.2.4. Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2019-2027 (USD Billion)
    • 1.2.5. Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Inflammatory Bowel Disease Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Inflammatory Bowel Disease Treatment Market Dynamics

  • 3.1. Inflammatory Bowel Disease Treatment Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of Crohn's disease and ulcerative colitis
      • 3.1.1.2. Robust product pipeline
      • 3.1.1.3. Emergence of biosimilars
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing geriatric population

Chapter 4. Global Inflammatory Bowel Disease Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Inflammatory Bowel Disease Treatment Market, by Type:

  • 5.1. Market Snapshot
  • 5.2. Global Inflammatory Bowel Disease Treatment Market by Type, Performance - Potential Analysis
  • 5.3. Global Inflammatory Bowel Disease Treatment Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
  • 5.4. Inflammatory Bowel Disease Treatment Market, Sub Segment Analysis
    • 5.4.1. Crohn's disease
    • 5.4.2. Ulcerative colitis

Chapter 6. Global Inflammatory Bowel Disease Treatment Market, by Drug Class:

  • 6.1. Market Snapshot
  • 6.2. Global Inflammatory Bowel Disease Treatment Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Inflammatory Bowel Disease Treatment Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
  • 6.4. Inflammatory Bowel Disease Treatment Market, Sub Segment Analysis
    • 6.4.1. Aminosalicylates
    • 6.4.2. Corticosteroids
    • 6.4.3. TNF inhibitors
    • 6.4.4. IL inhibitors
    • 6.4.5. Anti-integrin
    • 6.4.6. JAK inhibitors
    • 6.4.7. Others

Chapter 7. Global Inflammatory Bowel Disease Treatment Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Inflammatory Bowel Disease Treatment Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Inflammatory Bowel Disease Treatment Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
  • 7.4. Inflammatory Bowel Disease Treatment Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Injectable

Chapter 8. Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Inflammatory Bowel Disease Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Inflammatory Bowel Disease Treatment Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
  • 8.4. Inflammatory Bowel Disease Treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacy
    • 8.4.2. Retail Pharmacy
    • 8.4.3. Online Pharmacy

Chapter 9. Global Inflammatory Bowel Disease Treatment Market, Regional Analysis

  • 9.1. Inflammatory Bowel Disease Treatment Market, Regional Market Snapshot
  • 9.2. North America Inflammatory Bowel Disease Treatment Market
    • 9.2.1. U.S. Inflammatory Bowel Disease Treatment Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
      • 9.2.1.2. Drug class breakdown estimates & forecasts, 2018-2027
      • 9.2.1.3. Route of Administration breakdown estimates & forecasts, 2018-2027
      • 9.2.1.4. Distribution Channel breakdown estimates & forecasts, 2018-2027
    • 9.2.2. Canada Inflammatory Bowel Disease Treatment Market
  • 9.3. Europe Inflammatory Bowel Disease Treatment Market Snapshot
    • 9.3.1. U.K. Inflammatory Bowel Disease Treatment Market
    • 9.3.2. Germany Inflammatory Bowel Disease Treatment Market
    • 9.3.3. France Inflammatory Bowel Disease Treatment Market
    • 9.3.4. Spain Inflammatory Bowel Disease Treatment Market
    • 9.3.5. Italy Inflammatory Bowel Disease Treatment Market
    • 9.3.6. Rest of Europe Inflammatory Bowel Disease Treatment Market
  • 9.4. Asia-Pacific Inflammatory Bowel Disease Treatment Market Snapshot
    • 9.4.1. China Inflammatory Bowel Disease Treatment Market
    • 9.4.2. India Inflammatory Bowel Disease Treatment Market
    • 9.4.3. Japan Inflammatory Bowel Disease Treatment Market
    • 9.4.4. Australia Inflammatory Bowel Disease Treatment Market
    • 9.4.5. South Korea Inflammatory Bowel Disease Treatment Market
    • 9.4.6. Rest of Asia Pacific Inflammatory Bowel Disease Treatment Market
  • 9.5. Latin America Inflammatory Bowel Disease Treatment Market Snapshot
    • 9.5.1. Brazil Inflammatory Bowel Disease Treatment Market
    • 9.5.2. Mexico Inflammatory Bowel Disease Treatment Market
  • 9.6. Rest of The World Inflammatory Bowel Disease Treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. AbbVie Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Biogen
    • 10.2.3. Johnson & Johnson Services, Inc.
    • 10.2.4. Amgen Inc.
    • 10.2.5. UCB S.A.
    • 10.2.6. Novartis AG
    • 10.2.7. Takeda Pharmaceutical Company Limited
    • 10.2.8. Merck & Co., Inc.
    • 10.2.9. Pfizer Inc.
    • 10.2.10. Lilly

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
Back to Top
전화 문의
F A Q